Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse MKT  >  Xtant Medical Holdings Inc    XTNT

XTANT MEDICAL HOLDINGS INC (XTNT)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 01/15 03:59:55 pm
2.16 USD   -3.57%
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Xtant Medical : Announces Appointment of Chief Operations Officer

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 05:30am EST

(GlobeNewswire) - Xtant Medical Holdings, Inc.(NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment ofRonald Berlin as Vice President & Chief Operations Officer, effective January 1, 2019. Mr. Berlin will report to Michael Mainelli, Xtants Interim Chief Executive Officer.

Ron is an accomplished healthcare executive with significant operations and quality management expertise and we are pleased that he has joined our executive management team, said Michael Mainelli. In addition to the operational leadership he will provide to the organization, he is a strong strategic, cross-functional leader. His appointment continues our commitment to building a highly skilled management team.

Ron Berlin brings over 35 years of operations experience to Xtant. Most recently, Mr. Berlin served as Vice President of Global Operations for CoorsTek Medical. Prior to that role, he held positions of Vice President, Global Strategic Sourcing and Procurement and Vice President, Operations for Integra LifeSciences. Earlier in his career, he was Vice President of Global Operations at Stryker Orthopaedics, which was at the time a division of Stryker Corporation. He is well versed in all aspects of medical device and tissue processing operations and quality assurance. He has a proven track record for improving compliance and quality, cost effectiveness, asset utilization, and continuous improvement programs based on Six Sigma, Kaizen, Lean Implementation, as well as managing the implementation of M&A programs.

Im particularly pleased to be joining this exceptional, newly appointed executive leadership team and look forward to helping the Company continue to transform its business and drive shareholder value, said Ron Berlin.

AboutXtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc.(www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

COMPANY CONTACTKathie Lenzen, Chief Financial Officer406.388.0480klenzen@xtantmedical.com

(c) Palestine News Network, 2003 - 2019 Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on XTANT MEDICAL HOLDINGS INC
01/12XTANT MEDICAL : Announces Appointment of Chief Operations Officer
AQ
01/11Xtant Medical Announces Appointment of Chief Operations Officer
GL
2018XTANT MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
AQ
2018XTANT MEDICAL HOLDINGS, INC. : Results of Operations and Financial Condition, Fi..
AQ
2018Xtant Medical to Issue Third Quarter 2018 Results on November 14, 2018
GL
2018XTANT MEDICAL : Announces Appointment of Interim CEO
AQ
2018XTANT MEDICAL HOLDINGS, INC. : Change in Directors or Principal Officers, Regula..
AQ
2018Xtant Medical Announces Appointment of Interim CEO
GL
2018XTANT MEDICAL HOLDINGS, INC. : Changes in Registrant's Certifying Accountant, Fi..
AQ
2018XTANT MEDICAL : Announces Amendments to Credit Facility and Issuance of Warrants
AQ
More news
Financials ($)
Sales 2018 71,4 M
EBIT 2018 -7,73 M
Net income 2018 -19,3 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 0,41x
Capi. / Sales 2019 0,41x
Capitalization 29,5 M
Chart XTANT MEDICAL HOLDINGS INC
Duration : Period :
Xtant Medical Holdings Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 6,00 $
Spread / Average Target 168%
EPS Revisions
Managers
NameTitle
Michael R. Mainelli Chief Executive Officer & Director
Anthony DeFalco Vice President-Product Development & Operations
Kathie J. Lenzen CFO & SVP-Finance & Administration
Gregory A. Juda Chief Scientific Officer
John K. Bakewell Director
Sector and Competitors
1st jan.Capitalization (M$)
XTANT MEDICAL HOLDINGS INC39.13%30
THERMO FISHER SCIENTIFIC5.22%94 622
DANAHER CORPORATION1.86%72 957
INTUITIVE SURGICAL7.63%57 410
BOSTON SCIENTIFIC CORPORATION-0.08%48 862
ILLUMINA1.85%43 981